Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trial.
about
Mortality results from a randomized prostate-cancer screening trialProstate-Specific Antigen (PSA)-Based Population Screening for Prostate Cancer: An Economic AnalysisProstate-Specific Antigen (PSA)-Based Population Screening for Prostate Cancer: An Evidence-Based AnalysisQuality of life issues in men undergoing androgen deprivation therapy: a reviewProstate-specific antigen-based population screening for prostate cancer: current status in Japan and future perspective in AsiaQuantification of length-bias in screening trials with covariate-dependent test sensitivity.Calibrating disease progression models using population data: a critical precursor to policy development in cancer controlEvaluation of the Prostate Imaging Reporting and Data System for Magnetic Resonance Imaging Diagnosis of Prostate Cancer in Patients with Prostate-specific Antigen <20 ng/mlProCOC: the prostate cancer outcomes cohort study.National Cancer Institute Patient Navigation Research Program: methods, protocol, and measures.Long-term disease-specific functioning among prostate cancer survivors and noncancer controls in the prostate, lung, colorectal, and ovarian cancer screening trial.Prostate cancer severity among low income, uninsured men.Correlation between CT perfusion and clinico-pathological features in prostate cancer: a prospective study.High prevalence of screen detected prostate cancer in West Africans: implications for racial disparity of prostate cancer.Cancer screening in renal transplant recipients: what is the evidence?Combining urinary detection of TMPRSS2:ERG and PCA3 with serum PSA to predict diagnosis of prostate cancer.Do racial disparities exist in the use of prostate cancer screening and detection tools in veterans?Best practice in primary care pathology: review 4Prostate-specific antigen in the early detection of prostate cancer.Population-based case-control study of PSA and DRE screening on prostate cancer mortality.The role of prevalence in the diagnosis of prostate cancer.Yearly prostate specific antigen and digital rectal examination fluctuations in a screened population.Epigenetics and epigenetic alterations in pancreatic cancer.Economic evaluation of prostate cancer screening with prostate-specific antigen.Anniversary paper: evaluation of medical imaging systems.Mean sojourn time, overdiagnosis, and reduction in advanced stage prostate cancer due to screening with PSA: implications of sojourn time on screening.Lack of follow-up of prostate-specific antigen test results.Secular trends in prostate cancer mortality, incidence and treatment: England and Wales, 1975-2004.Prostate-specific antigen-based screening for prostate cancer: evidence, controversies and future perspectives.Prostate-specific antigen screening: proShould prostate-specific antigen screening be offered to asymptomatic men?The implementation of screening for prostate cancer.The Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial: the prostate cancer screening results in context.Randomized controlled screening trials for prostate cancer using prostate-specific antigen: a tale of contrasts.Risk stratification in prostate cancer screening.Cumulative probability of prostate cancer detection in biopsy according to free/total PSA ratio in men with total PSA levels of 2.1-10.0 ng/ml at population screening.Is it time to abandon the digital rectal examination? Lessons from the PLCO Cancer Screening Trial and peer-reviewed literature.Barriers to prostate cancer screening: psychological aspects and descriptive variables---is there a correlation?Validation in a multiple urology practice cohort of the Prostate Cancer Prevention Trial calculator for predicting prostate cancer detection.Cost-effectiveness of Prostate Health Index for prostate cancer detection.
P2860
Q24601536-39416D33-EC64-4413-BE81-3FEF9654B370Q26781089-634F908C-7C36-4D60-ABC2-726D06AEDB2CQ26781093-65E0004D-F86F-4C29-8DB7-63A12B0117DDQ27002887-AD3D5BBE-6472-4653-BDA0-C81AAB90FAACQ28085419-A228793E-1989-4862-BFBE-DD2BC204AABAQ30299933-74655DE9-6D68-4F5D-AB01-F7D0819D2B8DQ30496883-2C68ED62-25D4-4DEB-9F62-4A0F4E114FC4Q31106048-970605E0-9729-4364-847E-01C9F3C0EF84Q33344237-F11B16CB-BD0F-4C96-8D39-A11DB133C05BQ33379408-8A7B7701-B4C7-4619-A6DB-B3FDD16A6641Q34197475-792F0295-7481-4820-A5F3-253B233756ECQ34909140-7C49E23F-D334-4E92-B987-4711B597C9A9Q34993635-D9E16542-7F32-428E-ACE8-C583036C137DQ35096077-967F56D0-FBB8-4A7B-A951-525281D3BF48Q35153329-BD08BCD7-2049-4EEA-BA8A-B17A1EA4D6F5Q35535776-53DBE5D8-F2C3-49DA-A716-D2AD01FC46F0Q35562732-9E1697B8-70C8-4A44-B733-4E39D6004197Q35770305-97637E37-1BFE-4FF5-94FE-C103B6BBF1D3Q35840271-8EC18E4E-DBC9-4221-906D-2689A348ECF1Q36407753-90F68FC1-8AEA-401F-9C39-63AFCE70F3B3Q36555644-CD835609-FB49-4C18-A358-0448B18EFD5CQ36914829-F6645D5F-D865-421E-8A64-4139030221EBQ37041763-2715629E-2520-4259-913E-9ED830C13DD5Q37124961-4B25E72B-ECE7-4AF3-8A58-9F8E0674008CQ37126418-FA019A7F-BC0A-4D86-A025-EE729CB12DBFQ37160706-7314A084-5F4A-482D-858F-A1FBE891F5B8Q37309773-4C04A734-88B7-457C-9DCA-8A03E7799C3EQ37396566-A508C74C-8746-4760-A983-089FD833CCE9Q37430370-58622B89-1EBF-4C46-98AB-CCCE51EF9F91Q37707943-2410C8B1-B90A-4D91-8122-7DCF9DC2841EQ37774352-712CFD21-FBE6-4407-8387-497D11A8D49AQ37777325-B750AAAB-FB58-4565-BDEF-5FDBF6468B3CQ37878463-E2F88648-0C2D-483B-A6E4-FBF11785D5C6Q37960825-04EB7725-53C8-413A-8EF4-FF2022990623Q38068114-6D3B1D24-A6E2-44E2-9EBF-3BD2432A4C9FQ39325081-536ABB6D-FAB4-4C5C-A6C7-54072598E20CQ39708636-55360E08-A9C1-4749-BF8E-B12D190683A4Q39828964-A3ABBF5A-B73C-46A1-B40F-06E4632755F7Q39904254-5142B6D2-F33A-4E24-81EB-D430B64C7155Q40007049-1EDC6F92-0D00-4B73-BE5A-E69C691F2D60
P2860
Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trial.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Prostate Cancer Screening in t ...... g round of a randomized trial.
@en
Prostate Cancer Screening in t ...... g round of a randomized trial.
@nl
type
label
Prostate Cancer Screening in t ...... g round of a randomized trial.
@en
Prostate Cancer Screening in t ...... g round of a randomized trial.
@nl
prefLabel
Prostate Cancer Screening in t ...... g round of a randomized trial.
@en
Prostate Cancer Screening in t ...... g round of a randomized trial.
@nl
P2093
P2860
P356
P1476
Prostate Cancer Screening in t ...... g round of a randomized trial.
@en
P2093
Barnett S Kramer
David Chia
David L Levin
Douglas Reding
E David Crawford
Edward P Gelmann
Gerald L Andriole
Grant Izmirlian
John K Gohagan
Lawrence R Ragard
P2860
P304
P356
10.1093/JNCI/DJI065
P407
P577
2005-03-01T00:00:00Z